• Senior bioanalytical professional with over 20 years extensive experience in CRO and pharmaceutical/biotech industry. • Strong leadership in both project management and team building. Directed teams to provide high quality and high throughput in-vitro in-vivo bioanalysis in support of pharmacokinetic (PK), drug metabolism, pharmacology and toxicokinetic (TK) studies for researches in oncology, inflammation, cardiovascular, CNS and metabolic disease therapeutic areas.• Hands on expertise in LC-MS/MS, GC-MS, ICP-MS, HPLC, ELISA based bioanalytical method development and validation for small and large molecules, and biomarkers. • Rich experience in outsourcing and managing GLP, GCP bioanalysis in CROs. Successfully managed bioanalytical work for > 50 GLP preclinical studies and > 20 phase I-III clinical studies. • Profound understanding of FDA, EMA, ICH regulations and guidance. Experience in FDA audits. • Participated in multiple IND and NDA submissions.• Solid working knowledge in ADME, PK/PD, toxicology, and clinical pharmacology. Actively involved in multi-discipline drug discovery and development processes.